Experimental evidence demonstrates improved BCAA metabolism in type 2 diabetes through Bacteroides uniformis, suggesting potential probiotic use.
The present study demonstrates that Bu exerts multi-target modulation of the gut microbiota-metabolic axis, providing experimental evidence for its potential as a next-generation probiotic for T2DM prevention and treatment and associates the improvement with altered BCAA metabolism.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: